NASDAQ$WAY

Waystar Holding Corp · Q4 2024 earnings

Q4 2024 earnings · · Before market open · Investor relations

Briefing

Waystar Holding Corp reported strong Q4 2024 results with revenue and net income growth.

Waystar Holding Corp delivered strong financial performance in Q4 2024, with revenue increasing 18% year-over-year to $244.1 million. Net income reached $19.1 million, while non-GAAP net income stood at $52.1 million. The company reported a net income margin of 8% and an adjusted EBITDA margin of 41%. Revenue growth was driven by subscription and volume-based segments, both increasing significantly compared to the prior year.

  • Revenue grew 18% year-over-year to $244.1 million.
  • Net income reached $19.1 million with a margin of 8%.
  • Non-GAAP net income totaled $52.1 million with adjusted EBITDA of $100.2 million.
  • Subscription and volume-based revenue segments both showed strong growth.

Headline financials

Total Revenue

$244M

Previous: $207M+18.1%
EPS (adj)

$0.29

Previous: -$0.09+435.3%
Clients with >$100K LTM Revenue

1.2K

No prior period
Net Income

$19.1M

Previous: -$14.4M+232.4%
Operating Income

$53.1M

Previous: $38.8M+37.0%
Gross Profit

$165M

Previous: $94.8M+73.6%

Revenue & EPS history

Waystar Holding Corp · Revenue · Quarterly

$244M

Q4 2024+18.1%vs Q4 2023
Beat estimate in 7 of 7 quarters(100%)
ActualEstimate

Revenue by segment

Waystar Holding Corp · $223M total across 2 segments · Q1 2024

  • Volume-Based Revenue
    $117M
  • Subscription Revenue
    $106M

Forward guidance

Waystar expects continued revenue growth and strong adjusted EBITDA performance in FY 2025.

Tailwinds

  • Total revenue expected to be between $1.0 billion and $1.016 billion.
  • Adjusted EBITDA projected between $399 million and $407 million.
  • Non-GAAP net income forecasted to range from $237 million to $243 million.
  • Non-GAAP EPS expected to be between $1.29 and $1.32.
  • Company remains focused on expanding its cloud-based healthcare payment solutions.

Headwinds

  • Potential impact of macroeconomic conditions on client spending.
  • Competitive pressures in the healthcare payment technology industry.
  • Regulatory uncertainties that may affect operational costs.
  • Stock-based compensation expenses may impact GAAP net income.
  • Fluctuations in transaction volume could affect revenue growth projections.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 9 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

+3.4%

Avg return

Earnings day

+3.3%

Avg return

5 days after

+4.1%

Avg return

30 days after

67%

6 / 9 earnings

Positive

+9.2%

Q3 2023

Best reaction

-13.4%

Q1 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-13.4%-18.4%-21.3%
Q4 2025+8.6%+11.9%+10.6%
Q3 2025-6.5%-5.4%-6.8%
Q1 2025+6.2%+8.7%+7.6%
Q4 2024-0.5%-6.9%-15.9%
Q3 2024+9.2%+8.1%+6.6%
Q3 2023+9.2%+8.1%+6.6%
Q2 2023+8.9%+11.6%+24.9%
Q2 2024+8.9%+11.6%+24.9%
Q1 2024
Q4 2023
Q1 2023
Q4 2022
Q3 2022
Q2 2022
Q1 2022
Q4 2021
Q3 2021

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro